{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:40:00Z","timestamp":1758818400171},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clinthera.2016.10.011","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T21:04:40Z","timestamp":1482095080000},"page":"2610-2621","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Population Pharmacokinetic\u2013Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects"],"prefix":"10.1016","volume":"38","author":[{"given":"Hyang-Ki","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Ah","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoe","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Lyul","family":"Ghim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-Dae","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boaz","family":"Mendzelevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.10.011_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1992.tb31002.x","article-title":"Acquired long QT syndrome due to antiarrhythmic drugs and bradyarrhythmias","volume":"644","author":"Kasanuki","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinthera.2016.10.011_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40264-013-0016-z","article-title":"Dealing with global safety issues: was the response to QT-liability of non-cardiac drugs well coordinated?","volume":"36","author":"Stockbridge","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2016.10.011_bib3","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0091270004266843","article-title":"Sex-related differences in the pharmacokinetics of oral ciprofloxacin","volume":"44","author":"Overholser","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bcp.12168","article-title":"Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects","volume":"77","author":"Taubel","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0091270010381498","article-title":"Population pharmacokinetic and concentration\u2014QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies","volume":"51","author":"Florian","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mcp.2000.111482","article-title":"Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects","volume":"68","author":"Demolis","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.10.011_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0091270011398361","article-title":"Reevaluation of moxifloxacin pharmacokinetics and their direct effect on the QT interval","volume":"52","author":"Grosjean","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0014-2999(00)00694-4","article-title":"Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration","volume":"406","author":"Patmore","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00002018-200124050-00001","article-title":"Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling","volume":"24","author":"Malik","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.clinthera.2016.10.011_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4065\/78.12.1479","article-title":"Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome","volume":"78","author":"Ackerman","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2016.10.011_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2125.2012.04415.x","article-title":"Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?","volume":"75","author":"Shah","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib12","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12684","article-title":"Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study","volume":"80","author":"Morganroth","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2125.2011.04110.x","article-title":"Comparison of the effects of levofloxacin on QT\/QTc interval assessed in both healthy Japanese and Caucasian subjects","volume":"73","author":"Sugiyama","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib14","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2016.10.011_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/B:JOPA.0000012998.04442.1f","article-title":"Simultaneous vs. sequential analysis for population PK\/PD data I: best-case performance","volume":"30","author":"Zhang","year":"2003","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.clinthera.2016.10.011_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/0735-1097(94)90654-8","article-title":"Relation between QT intervals and heart rates from 40 to 120 beats\/min in rest electrocardiograms of men and a simple method to adjust QT interval values","volume":"23","author":"Karjalainen","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0735-1097(95)00426-2","article-title":"Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events","volume":"27","author":"Molnar","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib18","doi-asserted-by":"crossref","first-page":"E609","DOI":"10.1208\/aapsj070363","article-title":"Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT\/QTc prolongation","volume":"7","author":"Piotrovsky","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.clinthera.2016.10.011_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00228-011-1192-3","article-title":"Mixed-effect circadian rhythm model for human erythrocyte acetylcholinesterase activity\u2014application to the proof of concept of cholinesterase inhibition by acorn extract in healthy subjects with galantamine as positive control","volume":"68","author":"Han","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0188-4409(00)00242-3","article-title":"Pharmacokinetic-pharmacodynamic modeling: why?","volume":"31","author":"Perez-Urizar","year":"2000","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clinthera.2016.10.011_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10928-007-9057-1","article-title":"The lasso\u2014a novel method for predictive covariate model building in nonlinear mixed effects models","volume":"34","author":"Ribbing","year":"2007","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.clinthera.2016.10.011_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jiac.2014.06.001","article-title":"Population pharmacokinetics of intravenous moxifloxacin 400 mg once-daily dosage in infected patients","volume":"20","author":"Zhu","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.clinthera.2016.10.011_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/AAC.01478-13","article-title":"Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients","volume":"58","author":"Zvada","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.10.011_bib24","series-title":"Pharmacokinetic-Pharmacodynamic Modeling and Simulation","author":"Bonate","year":"2005"},{"key":"10.1016\/j.clinthera.2016.10.011_bib25","doi-asserted-by":"crossref","unstructured":"Lavielle M. Mixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools. CRC Press Inc., Boca Raton, USA; 2014","DOI":"10.1201\/b17203"},{"key":"10.1016\/j.clinthera.2016.10.011_bib26","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1211\/002235702320402071","article-title":"Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats","volume":"54","author":"Hayakawa","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib27","first-page":"299","article-title":"Penetration of fleroxacin into human lung, muscle, and fat tissue","volume":"18","author":"Cakmakci","year":"1992","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.clinthera.2016.10.011_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2016.10.011_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00235103","article-title":"Gender differences in strength and muscle fiber characteristics","volume":"66","author":"Miller","year":"1993","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2125.2006.02793.x","article-title":"Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects","volume":"63","author":"Shin","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005344-199908000-00015","article-title":"Female gender is a risk factor for torsades de pointes in an in vitro animal model","volume":"34","author":"Liu","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.clinthera.2016.10.011_bib32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1540-8167.2001.00538.x","article-title":"Female gender is a risk factor for drug-induced long QT and cardiac arrhythmias in an in vivo rabbit model","volume":"12","author":"Lu","year":"2001","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T15:47:06Z","timestamp":1542296826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816307974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0149291816307974"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.10.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population Pharmacokinetic\u2013Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}